immunotherapy Clinical Trials and Research
Also known as: immune therapy, biological therapy, biotherapy, immune-oncology, cancer immunotherapy, cellular therapy
Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. Clinical trial research is focused on developing new immunotherapy drugs, improving their effectiveness, and understanding how they can be combined with other treatments. Find a Trial helps patients search for active studies in this area.
Common questions about immunotherapy clinical trials
What is immunotherapy and how does it work?
Immunotherapy uses substances to stimulate or suppress the immune system to help the body fight diseases like cancer. It works by enhancing the immune system's natural ability to recognize and destroy diseased cells, often by targeting specific pathways. Data from ClinicalTrials.gov and NIH RePORTER show ongoing research into various mechanisms.
What types of conditions are treated with immunotherapy?
Immunotherapy is primarily used in cancer treatment, including melanoma, lung cancer, kidney cancer, and lymphomas. It is also being explored for autoimmune diseases and infectious diseases. ClinicalTrials.gov lists studies across a wide range of conditions utilizing immunotherapy approaches.
What are common types of immunotherapy being studied in clinical trials?
Common types include checkpoint inhibitors, CAR T-cell therapy, monoclonal antibodies, and therapeutic vaccines. These therapies aim to unleash or enhance the immune system's ability to target specific diseases. Research on ClinicalTrials.gov and NIH RePORTER explores novel applications and combinations.
Who is eligible for immunotherapy clinical trials?
Eligibility criteria vary widely depending on the specific trial, condition, and type of immunotherapy. Factors often include the patient's diagnosis, disease stage, prior treatments, and overall health status. Detailed criteria are listed on ClinicalTrials.gov for each study.
What are the different phases of immunotherapy clinical trials?
Immunotherapy trials progress through phases: Phase 1 assesses safety, Phase 2 evaluates effectiveness and side effects, and Phase 3 compares new treatments to existing ones. Phase 4 monitors approved treatments long-term. This structured approach ensures thorough evaluation, as tracked on ClinicalTrials.gov.
Are there common side effects associated with immunotherapy?
Immunotherapy can cause side effects by activating the immune system, leading to inflammation in various organs. Common side effects include fatigue, skin rash, and flu-like symptoms, but more serious immune-related adverse events can occur. ClinicalTrials.gov reports on safety profiles in ongoing studies.
Do patients pay to participate in immunotherapy clinical trials?
Generally, patients do not pay for the investigational drug or study-related procedures in clinical trials. However, standard medical care costs, like doctor visits or hospital stays, may still be the patient's responsibility or covered by insurance. This information is detailed on ClinicalTrials.gov.
What are researchers hoping to achieve with new immunotherapy studies?
Researchers aim to improve treatment efficacy, reduce side effects, and expand immunotherapy's use to more conditions and patient populations. Studies on ClinicalTrials.gov and NIH RePORTER focus on combination therapies, predictive biomarkers, and overcoming resistance mechanisms to enhance patient outcomes.
How to find a immunotherapy trial that fits you
- Describe your immunotherapy situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all immunotherapy trials →